SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-205491
Filing Date
2021-07-01
Accepted
2021-07-01 06:22:05
Documents
23
Period of Report
2021-07-01
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d172758d8k.htm   iXBRL 8-K 30942
2 EX-99.1 d172758dex991.htm EX-99.1 9680
3 EX-99.2 d172758dex992.htm EX-99.2 27235
7 GRAPHIC g172758ex99_1s1g1.jpg GRAPHIC 420357
8 GRAPHIC g172758ex99_1s2g1.jpg GRAPHIC 619540
9 GRAPHIC g172758ex99_1s3g1.jpg GRAPHIC 209369
10 GRAPHIC g172758ex99_1s4g1.jpg GRAPHIC 214359
11 GRAPHIC g172758ex99_1s5g1.jpg GRAPHIC 187145
12 GRAPHIC g172758ex99_1s6g1.jpg GRAPHIC 193623
13 GRAPHIC g172758ex99_1s7g1.jpg GRAPHIC 208683
14 GRAPHIC g172758ex99_1s8g1.jpg GRAPHIC 308167
15 GRAPHIC g172758img001.jpg GRAPHIC 14755
  Complete submission text file 0001193125-21-205491.txt   3482086

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA oyst-20210701.xsd EX-101.SCH 2893
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE oyst-20210701_lab.xml EX-101.LAB 18886
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oyst-20210701_pre.xml EX-101.PRE 11860
16 EXTRACTED XBRL INSTANCE DOCUMENT d172758d8k_htm.xml XML 3477
Mailing Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540
Business Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540 (609) 382-9032
Oyster Point Pharma, Inc. (Filer) CIK: 0001720725 (see all company filings)

IRS No.: 811030955 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39112 | Film No.: 211063963
SIC: 2836 Biological Products, (No Diagnostic Substances)